Influence of cannabis use on severity of hepatitis C disease - Wikidata - awgldk - TriplyDB

Influence of cannabis use on severity of hepatitis C disease

Influence of cannabis use on severity of hepatitis C disease

http://www.wikidata.org/entity/Q35250832

about

Narrative review of the safety and efficacy of marijuana for the treatment of commonly state-approved medical and psychiatric disorders Clinical Advances in Fibrosis Progression of Chronic Hepatitis B and C Medical consequences of marijuana use: a review of current literature Cannabinoid receptor 2-63 QQ variant is associated with persistently normal aminotransferase serum levels in chronic hepatitis C Eligibility of persons who inject drugs for treatment of hepatitis C virus infection.Progression of biopsy-measured liver fibrosis in untreated patients with hepatitis C infection: non-Markov multistate model analysis Cannabinoids and Viral Infections.Use of cannabinoids as a novel therapeutic modality against autoimmune hepatitis.Marijuana use in hepatitis C infection does not affect liver biopsy histology or treatment outcomes.The endocannabinoid system as a key mediator during liver diseases: new insights and therapeutic openings Elevated levels of endocannabinoids in chronic hepatitis C may modulate cellular immune response and hepatic stellate cell activation.Cannabinoid receptor type I modulates alcohol-induced liver fibrosis.Continued Substance Use Among People Living With HIV-Hepatitis-C Co-Infection and Receiving Antiretroviral Therapy Marijuana smoking does not accelerate progression of liver disease in HIV-hepatitis C coinfection: a longitudinal cohort analysis Association of HIV infection, hepatitis C virus infection, and metabolic factors with liver stiffness measured by transient elastography.Therapeutic Use of Cannabis in Inflammatory Bowel Disease.Liver Illness and Psychiatric Patients.Future treatments of cirrhosis.Medical marijuana for digestive disorders: high time to prescribe?Effects of cannabinoids and their receptors on viral infections.Natural history of HCV infection.Marijuana Smoking in Patients With Leukemia.Cannabis use provides symptom relief in patients with inflammatory bowel disease but is associated with worse disease prognosis in patients with Crohn's disease.Cannabinoid receptor 2-63 RR variant is independently associated with severe necroinflammation in HIV/HCV coinfected patients.Potential of Cannabidiol for the Treatment of Viral Hepatitis.Marijuana Use Is Not Associated With Progression to Advanced Liver Fibrosis in HIV/Hepatitis C Virus-coinfected Women.Recommendations for the management of hepatitis C virus infection among people who inject drugs.Unmet health care needs and hepatitis C infection among persons who inject drugs in Denver and Seattle, 2009.Recommendations for the management of hepatitis C virus infection among people who inject drugs.History of marijuana use does not affect outcomes on the liver transplant waitlist.Natural History of Hepatitis C.Study of the effect of Cannabis sativa on liver and brain damage caused by thioacetamide Cannabis sativa exacerbates hepatic injury caused by acetaminophen or carbon tetrachloride in rats Reduced Incidence and Better Liver Disease Outcomes among Chronic HCV Infected Patients Who Consume Cannabis

P2860

Q22299116-4D0626D8-672C-4896-84B5-B3C5AAAA0C08 Q26781789-95BA0F21-A828-4616-8198-BFFF700718D8 Q28301998-E6495106-E9A4-4A42-9E66-B3731091BBEC Q28539814-0E198B50-BD09-4C42-B566-CBCC7FFE543E Q30429470-4E4D9069-36C7-4153-A6EB-E7D6562BB629 Q33921088-BEF8D42F-36E6-48D5-AA73-3C48D40A148B Q33992923-FCAD553B-FA2D-4080-9F9D-A0B68F1EF441 Q34069579-4B0784BA-CCF4-48CE-9307-141E1BD0C015 Q34088634-703F1D17-B20F-41AA-9EEC-66D799CF6A7A Q35193292-11ECB948-9DBA-47F3-84C1-3904FAD95D01 Q35585455-7CC5EF46-94BF-4951-9045-773FFDD1FC3B Q35876795-7CEAA0D9-755D-4D9E-9D46-9FF8BDE028AA Q36733235-C91A7EEB-C1B0-4DD0-A479-66EE686819F1 Q37085008-EE9C41B4-A660-4F27-A2EA-7CD8462EFA79 Q37272320-3C642EDD-BEC0-4DB6-B660-DD6C56943A79 Q37540208-8003E09B-9FC1-4572-B536-9E2484B97CD3 Q37587062-A78745DE-96C0-42C2-B0B8-2941325C494B Q38218607-2234D77E-E764-4C04-A336-5E625F705F6B Q38246940-3FEF9661-4338-4065-A35E-9E3859D5FA7F Q38522557-83DCE9B9-CFA7-422B-8C97-EA5E5806B57E Q38552179-162B028F-F01A-4E3F-ADB7-CA679F337D2F Q39135012-779432B5-86FE-4B01-9A39-D11EED015DD7 Q39213927-E92C8D04-DD63-4251-820C-655903680DDE Q40113130-6152C7E8-03AB-44AD-BFA4-CC62762F1D46 Q40312314-66696B9F-C4CD-4591-9727-7DBBBE1EE132 Q40659740-4FAB96CB-25E6-4DED-BA41-749CFB1D7DA5 Q41047662-1486AB76-EC5F-4EE6-AE1C-C394AD56D605 Q42208893-2FCD9643-1B25-489E-BD0D-62CE97F9D7F0 Q42280296-2B26D667-9C2C-476E-A039-539D664631ED Q47562252-7B553B67-44EA-411B-808F-D4E6DAA3805B Q50934392-D3E8E412-5FC6-4F5E-8A7A-7408E25BC75E Q57729876-6E83C5B7-2F4E-47F0-A4C7-8EED0E5D444E Q57729890-0BC6FF02-D43E-4AC0-9E2A-9CA6BBFD4B48 Q57821728-E55CCADB-0E72-449E-B1A4-5B371B652A90

P2860

Influence of cannabis use on severity of hepatitis C disease

http://www.wikidata.org/entity/Q35250832

description

2008 nî lūn-bûn

@nan

2008 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Influence of cannabis use on severity of hepatitis C disease

@ast

Influence of cannabis use on severity of hepatitis C disease

@en

type

label

Influence of cannabis use on severity of hepatitis C disease

@ast

Influence of cannabis use on severity of hepatitis C disease

@en

prefLabel

Influence of cannabis use on severity of hepatitis C disease

@ast

Influence of cannabis use on severity of hepatitis C disease

@en

P1433

Q35250832-BA7F0291-844A-471C-BE6D-416B4087CCFD

P1476

Q35250832-1C0C1DBF-FE7E-4517-AA90-F2881EA888BB

P2093

Q35250832-1F794A3A-B6F8-4B55-B137-744A81395AB9

Q35250832-31902B80-FED3-47A0-8B13-58B6B3094F34

Q35250832-52918EB7-2F28-4D55-9539-8FA7772A47FA

Q35250832-54303310-75B7-4051-B161-FA081011829B

Q35250832-68965EFD-8BBE-4F8C-982A-EF4B30637D17

Q35250832-9EEA3379-2D52-4AE6-95CD-7B264660DDCF

Q35250832-B096F931-818C-4CBB-98C2-EBBDAB3A760F

P2860

Q35250832-0756BB57-F272-482E-B52E-8281F76C952B

Q35250832-164B65E5-0951-41A8-BC32-C1A9BE923940

Q35250832-16B4925C-8056-46AA-8AF9-A18BB768177E

Q35250832-1E52E872-8D5A-4DC3-AB61-B97F48351066

Q35250832-21A6C40F-BC9C-4684-8185-C062710FFA6E

Q35250832-3F068776-B637-403F-BC9B-EB8AB3DA1422

Q35250832-41EF96FA-FB6E-4285-A390-DDE5830F59BD

Q35250832-426F6420-01BE-4786-89C3-6DFD7F52FEFC

Q35250832-452D1191-0496-4F5F-89FB-DE5F54BC04AD

Q35250832-6031EDDF-4A48-4B5B-9BCA-B5912622A428

P304

Q35250832-C5461698-CF4B-4009-BEC8-FC6FD91F8FF8

P31

Q35250832-0F00F628-0442-45EC-BEEC-480077E83222

P356

Q35250832-17577736-7DBB-4101-AC25-2838BE3AE825

P407

Q35250832-74D8A59F-8CA5-47F6-8A8F-0B8E6F3CD5AF

P433

Q35250832-42324012-1A2F-4A94-A340-5065551BC00D

P478

Q35250832-81357036-0C1F-4FDF-AF7E-478135E7F12C

P577

Q35250832-882A3FB7-FFDF-4796-B827-45B0C1FBD1E3

P5875

Q35250832-598A0B3F-B3A6-4C22-8D2A-D3C7D3763C78

P698

Q35250832-78F39FE9-23AF-4144-B65F-34E2D867A619

P932

Q35250832-1E8667CA-2827-4781-99A3-905C6C4551A1

P356

J.CGH.2007.10.021

P1433

Clinical Gastroenterology and Hepatology

P1476

Influence of cannabis use on severity of hepatitis C disease

@en

P2093

Chengshi Jin

http://www.w3.org/2001/XMLSchema#string

Julie H Ishida

http://www.w3.org/2001/XMLSchema#string

Karly Louie

http://www.w3.org/2001/XMLSchema#string

Marion G Peters

http://www.w3.org/2001/XMLSchema#string

Norah A Terrault

http://www.w3.org/2001/XMLSchema#string

Peter Bacchetti

http://www.w3.org/2001/XMLSchema#string

Vivian Tan

http://www.w3.org/2001/XMLSchema#string

P2860

Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity

STEATOSIS IN CHRONIC HEPATITIS C: WHY DOES IT REALLY MATTER?

Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. Centers for Disease Control and Prevention

Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups

Histological grading and staging of chronic hepatitis

Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis

Natural history of chronic hepatitis C

Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions.

The past incidence of hepatitis C virus infection: implications for the future burden of chronic liver disease in the United States.

Alcohol use and hepatitis C.

P304

69-75

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.CGH.2007.10.021

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P577

2008-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5684103

http://www.w3.org/2001/XMLSchema#string

P698

18166478

http://www.w3.org/2001/XMLSchema#string

P932

3184401

http://www.w3.org/2001/XMLSchema#string